The Naval Medical Research Center (NMRC) recently signed a major research agreement with an industry partner to accelerate development of a promising new vaccine against enterotoxigenic E. coli (ETEC), the predominant cause of travelers' diarrhea.
Navy Medicine researchers announced a milestone April 28 in the decades-long effort to develop a highly effective malaria vaccine to protect military personnel.
The Navy Medicine research facility in Cairo is the first overseas Department of Defense (DoD) research laboratory to receive the College of American Pathologists Laboratory Accreditation.
A Navy Medicine research team invented a unique computer-based management tool for medical planners to better estimate supplies required to support combat, humanitarian, and peacekeeping missions.
The Naval Medical Research Center (NMRC) will soon begin a study to test a new vaccine that could help eliminate diseases that cripple armies, put travelers in sick beds and cause millions of child deaths in undeveloped countries.
The U.S. Naval Medical Research Center Detachment (NMRCD) Peru has joined a consortium of institutions from Peru, Brazil and the United States to help eliminate malaria from the Amazon region.
The Navy Medicine director for the Navy's Malaria Vaccine Program was appointed as the research coordinator of the U.S. Military Malaria Vaccine Program (USMMVP), Aug. 27.